Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Classifica tra le azioni #26679
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Prezzo delle azioni
$3.49
Ultima sincronizzazione: 2023-12-19
Capitalizzazione di mercato
$38.68M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Neoleukin Therapeutics, Inc. (NLTX)

Categoria

Cronologia dei frazionamenti azionari per Neoleukin Therapeutics, Inc. (NLTX)
L’azione Neoleukin Therapeutics, Inc. (simbolo: NLTX) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 20, 2026.
Una quota di NLTX acquistata prima di Aug 20, 2026 equivale oggi a 0 quote di NLTX.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti